Related to this topic: Equipment | Books | Your Experience | Other resources | Glossaries
Print options: Printer friendly version of this leaflet (html)     Other options:  AddThis Social Bookmark Button (what's this?)

PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Protein-losing Enteropathy

Description1

Protein-losing enteropathy (PLE) occurs in a number of gastro-intestinal conditions that cause excessive loss of serum proteins into the GI tract.
Three main mechanisms are involved:

Mucosal disease with ulceration with protein loss across disrupted mucosal surface

Lymphatic obstruction causing loss of protein rich chyle

Idiopathic alterations in mucous capillary permeability

Epidemiology

Because the condition is so multi-factorial, the prevalence rate is not known.

Presentation1,2

Consider PLE in any patient presenting with oedema, especially if this is against a background of gastrointestinal (GI) disease.

History

  • A dietary history should be taken to exclude malnutrition as a cause of reduced albumin synthesis.
  • Check the patient's medical history for information about renal disease (increased protein loss) or hepatic disease. (reduced albumin synthesis).
  • Ask about GI symptoms, in particular any symptoms suggestive of enteritis (e.g. diarrhoea, abdominal pain).
  • Ask about alcohol intake.
  • Check for a history of congenital heart disease, episodes of pericarditis, serious streptococcal infection, or prior heart surgery (increased interstitial pressure can be a cause).

Examination

  • Check the general nutritional status of the patient - e.g. height, weight, head circumference in children.
  • Look for signs of acute liver disease (e.g, enlarged liver, tenderness in the right upper quadrant).
  • Look for signs of chronic liver disease (eg, jaundice, splenomegaly, prominent veins on the abdomen).
  • Check for signs of right heart failure - e.g. ascites and jugular vein distension.
  • The finding of high blood pressure may suggest renal or cardiac disease.
  • Look for signs of GI pathology - e.g. abdominal tenderness, macroscopic or microscopic blood and mucus in the stool
Differential Diagnosis1,2
Investigations1,2
  • Serum proteins - by definition hypoalbuminaemia will be present.
  • Liver and renal disease should be excluded by the appropriate function tests.
  • Evidence of protein loss via the GI tract should be investigated in patients with oedema, hypoalbuminaemia and normal renal and liver function tests.
  • Raised alpha1-antitrypsin levels in stools is a marker for protein loss3 but is not very specific as this is also seen in liver disease.
  • Scintigraphy is a more accurate test. It involves the use of radio-labelled substances which are administered intravenously and then detected by the use of serial abdominal X-rays. The two common agents used are technetium labelled (Tc-99m) dextran4 or human serum albumin.5 These substances have been chosen because they are readily available (and therefore cheap), easy to administer, and inert.
Management1,2

Non-Drug

In lymphatic obstruction patients may be helped by low fat diet with medium chain triglyceride supplement.

Drugs

  • The underlying cause should be treated (e.g. diuretics for congestive cardiac failure).
  • Octreotide has shown to be useful in some patients.6 It is a potent inhibitor of many hormones affecting the gut and has a marked effect on reducing blood flow to the intestines.
  • Supplementation with fat-soluble vitamins may be helpful.
  • PLE is a common complication of the Fontan operation. This is a procedure carried out in children with severe congenital heart disease in which venous blood is diverted from the right atrium to the pulmonary arteries without passing through the right ventricle. Heparin produces benefits independent of its anticoagulant effect.7 Steroids can also be helpful, but the beneficial effect tends to be transient.8

Surgery

  • In patients who have undergone the Fontan procedure, making a window in the baffle that separates the systemic venous pathway from the pulmonary venous atrium has helped to resolve PLE, presumably due to a reduction in systemic venous pressure.
  • Cardiac transplant is occasionally used to treat intractable PLE in patients who have had previous heart surgery.
  • PLE after a Fontan operation associated with lymphangiectasia (blockage of the intestinal lymphatics) has been successfully treated by resection of the affected area of bowel.9
Prognosis

This depends on the underlying disease, but improved management techniques are reducing mortality and morbidity of many causes. More than half the patients presenting with PLE now reach partial or complete remission, but require regular monitoring of their nutritional status.10


Document references
  1. Wershil B Garcia A; Protein-Losing Enteropathy eMedicine.com 2006
  2. Wright R; Protein-Losing Enteropathy eMedicine.com 2005
  3. Crossley JR, Elliott RB; Simple method for diagnosing protein-losing enteropathies. Br Med J. 1977 Feb 12;1(6058):428-9.
  4. Kapoor S, Ratan SK, Kashyap R, et al; Detecting protein losing enteropathy by Tc-99m dextran scintigraphy: a novel experience. Indian J Pediatr. 2002 Sep;69(9):761-4. [abstract]
  5. Chiu NT, Lee BF, Hwang SJ, et al; Protein-losing enteropathy: diagnosis with (99m)Tc-labeled human serum albumin scintigraphy. Radiology. 2001 Apr;219(1):86-90. [abstract]
  6. Kuroiwa G, Takayama T, Sato Y, et al; Primary intestinal lymphangiectasia successfully treated with octreotide. J Gastroenterol. 2001 Feb;36(2):129-32. [abstract]
  7. Donnelly JP, Rosenthal A, Castle VP, et al; Reversal of protein-losing enteropathy with heparin therapy in three patients with univentricular hearts and Fontan palliation. J Pediatr. 1997 Mar;130(3):474-8. [abstract]
  8. Zellers TM, Brown K; Protein-losing enteropathy after the modified fontan operation: oral prednisone treatment with biopsy and laboratory proved improvement. Pediatr Cardiol. 1996 Mar-Apr;17(2):115-7. [abstract]
  9. Connor FL, Angelides S, Gibson M, et al; Successful resection of localized intestinal lymphangiectasia post-Fontan: role of (99m)technetium-dextran scintigraphy. Pediatrics. 2003 Sep;112(3 Pt 1):e242-7. [abstract]
  10. Madison Foundation; Protein-Losing Enteropathy

Internet and further reading Acknowledgements EMIS is grateful to Dr Laurence Knott for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2007.
DocID: 1730
Document Version: 21
DocRef: bgp1910
Last Updated: 1 Nov 2006
Review Date: 31 Oct 2008
Patient UK Current Health News








Health Matters



Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site



PS - Health and Poverty

Perhaps the biggest cause of ill health in the world is poverty. Help to Make Poverty History. For example, why not lend some of your money to disadvantaged communities to enable them to trade their way out of poverty through schemes such as Shared Interest.

See also MAKEPOVERTYHISTORY North East for details and links to campaigns against poverty.

^ Top of Page